Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

The Pharmacogenomics Journal
Arno C HesselsCoen A Stegeman

Abstract

The introduction of immunosuppressive therapy for ANCA-associated vasculitis (AAV) has greatly improved outcomes, though patients now accumulate damage from vasculitis activity and adverse effects of treatment. Prediction of treatment outcomes using gene variants might help reduce this damage by allowing for personalized treatment. Several studies have studied genetic polymorphisms in relation to treatment outcomes of AAV. This review gives an overview of these studies, discussing both gene polymorphisms associated with inflammatory pathways (potentially influencing disease outcomes such as activity, severity, and relapse risk) and pharmacogenetics (potentially influencing drug metabolism and/or drug response). Subsequently, potential benefits of testing genetic variants for AAV and the steps needed for its implementation in clinical practice are discussed. The conclusion of this review is that measurement of most polymorphisms is currently not indicated in clinical practice.

References

Feb 4, 1998·Current Opinion in Rheumatology·J W TervaertC G Kallenberg
Oct 8, 1999·Arthritis and Rheumatism·H M DijstelbloemJ W Tervaert
Mar 7, 2002·Arthritis Research·Eliane R PopaJan Willem Cohen Tervaert
Nov 13, 2002·Annual Review of Immunology·Fabienne MackayJeffrey Browning
Jul 4, 2003·The New England Journal of Medicine·David JayneUNKNOWN European Vasculitis Study Group
Oct 26, 2005·Journal of Autoimmunity·Markus KrumbholzEdgar Meinl
Oct 24, 2007·Annual Review of Immunology·Rosanne Spolski, Warren J Leonard
May 20, 2008·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Ron H N van Schaik
Feb 28, 2009·Arthritis and Rheumatism·Kari HemminkiKristina Sundquist
Mar 26, 2009·The Journal of Clinical Endocrinology and Metabolism·Lisa M L van WinsenBernard M J Uitdehaag
Jul 4, 2009·Annals of the Rheumatic Diseases·Mark A LittleUNKNOWN European Vasculitis Study (EUVAS) Group
Aug 21, 2009·Journal of the Peripheral Nervous System : JPNS·Marieke J H J DekkerBart C Jacobs
Nov 13, 2009·Annals of the New York Academy of Sciences·Laura ManenschijnElisabeth F C van Rossum
Apr 2, 2010·Rheumatology International·Pintip NgamjanyapornSuchela Janwityanujit
Jul 22, 2010·The New England Journal of Medicine·John H StoneUNKNOWN RAVE-ITN Research Group
Jan 29, 2011·Clinical Pharmacology and Therapeutics·M V RellingUNKNOWN Clinical Pharmacogenetics Implementation Consortium
Jul 20, 2012·The New England Journal of Medicine·Paul A LyonsKenneth G C Smith
Aug 2, 2013·The New England Journal of Medicine·Ulrich SpecksUNKNOWN RAVE-ITN Research Group
Sep 28, 2013·Clinical and Experimental Nephrology·J Charles Jennette
Feb 4, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Abraham C J StorkW-Ludo van der Pol

❮ Previous
Next ❯

Citations

Jun 22, 2021·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alexander R Rosenkranz, Vladimir Tesar

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.